Derrick L. Tao

886 total citations
20 papers, 552 citations indexed

About

Derrick L. Tao is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Derrick L. Tao has authored 20 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Internal Medicine, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Oncology. Recurrent topics in Derrick L. Tao's work include Venous Thromboembolism Diagnosis and Management (9 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Sarcoma Diagnosis and Treatment (4 papers). Derrick L. Tao is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (9 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Sarcoma Diagnosis and Treatment (4 papers). Derrick L. Tao collaborates with scholars based in United States, Palestinian Territory and Israel. Derrick L. Tao's co-authors include Adrián Mariño‐Enríquez, Leona A. Doyle, Craig D. Williams, Owen J. T. McCarty, Samuel Tassi Yunga, Joseph J. Shatzel, Jonathan A. Fletcher, Grant Eilers, Thomas G. DeLoughery and Jeffrey T. Czaplinski and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

Derrick L. Tao

18 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Derrick L. Tao United States 10 286 133 128 105 73 20 552
Mariella Sorarů Italy 9 118 0.4× 69 0.5× 51 0.4× 9 0.1× 158 2.2× 22 549
Angelika Bezan Austria 11 159 0.6× 177 1.3× 27 0.2× 17 0.2× 19 0.3× 16 389
Yoji Fukumoto Japan 19 498 1.7× 480 3.6× 25 0.2× 116 1.1× 24 0.3× 66 953
Doğan Uncu Türkiye 15 261 0.9× 348 2.6× 32 0.3× 27 0.3× 105 1.4× 96 704
Lee Chun Park South Korea 12 95 0.3× 111 0.8× 19 0.1× 14 0.1× 112 1.5× 30 374
Yanjie Hao China 16 307 1.1× 98 0.7× 326 2.5× 7 0.1× 303 4.2× 47 837
Yuichi Tomiki Japan 13 185 0.6× 312 2.3× 47 0.4× 55 0.5× 47 0.6× 140 687
Hirohiko Kuroda Japan 16 350 1.2× 347 2.6× 19 0.1× 103 1.0× 16 0.2× 46 681
I. L. Ray-Coquard France 13 231 0.8× 262 2.0× 27 0.2× 114 1.1× 48 0.7× 47 655
Ferdinando Cananzi Italy 15 378 1.3× 268 2.0× 41 0.3× 127 1.2× 49 0.7× 64 718

Countries citing papers authored by Derrick L. Tao

Since Specialization
Citations

This map shows the geographic impact of Derrick L. Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derrick L. Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derrick L. Tao more than expected).

Fields of papers citing papers by Derrick L. Tao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derrick L. Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derrick L. Tao. The network helps show where Derrick L. Tao may publish in the future.

Co-authorship network of co-authors of Derrick L. Tao

This figure shows the co-authorship network connecting the top 25 collaborators of Derrick L. Tao. A scholar is included among the top collaborators of Derrick L. Tao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derrick L. Tao. Derrick L. Tao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tao, Derrick L., Zhaoyu Sun, Venkatesh Rajamanickam, et al.. (2025). The responses of HNSCC patients to immunotherapy are shown by two novel co-expression patterns. npj Precision Oncology. 9(1). 217–217.
2.
Tao, Derrick L., et al.. (2022). Screening for occult cancer after unprovoked venous thromboembolism: Assessing the current literature and future directions. European Journal Of Haematology. 110(1). 24–31. 5 indexed citations
3.
Tao, Derrick L., Samuel Tassi Yunga, Craig D. Williams, & Owen J. T. McCarty. (2021). Aspirin and antiplatelet treatments in cancer. Blood. 137(23). 3201–3211. 80 indexed citations
4.
5.
Tao, Derrick L., et al.. (2021). Assessing the risk of thromboembolism in cancer patients receiving immunotherapy. European Journal Of Haematology. 108(4). 271–277. 20 indexed citations
6.
Tao, Derrick L., et al.. (2020). Phase I trials and therapeutic intent in the age of precision oncology: What is a patient's chance of response?. European Journal of Cancer. 139. 20–26. 8 indexed citations
7.
Tao, Derrick L., et al.. (2020). Antithrombotic Therapies in COVID-19 Disease: a Systematic Review. Journal of General Internal Medicine. 35(9). 2698–2706. 29 indexed citations
8.
Tao, Derrick L., Sven R. Olson, Thomas G. DeLoughery, & Joseph J. Shatzel. (2020). The efficacy and safety of DOACs versus LMWH for cancer‐associated thrombosis: A systematic review and meta‐analysis. European Journal Of Haematology. 105(3). 360–362. 17 indexed citations
9.
Serrano, César, Adrián Mariño‐Enríquez, Derrick L. Tao, et al.. (2019). Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours. British Journal of Cancer. 120(6). 612–620. 119 indexed citations
10.
Tao, Derrick L., et al.. (2018). Statistical significance of bevacizumab trials when considering the portfolio of all studies.. Journal of Clinical Oncology. 36(15_suppl). 6551–6551. 1 indexed citations
11.
Tao, Derrick L. & Vinay Prasad. (2018). Choice of control group in randomised trials of cancer medicine: are we testing trivialities?. The Lancet Oncology. 19(9). 1150–1152. 11 indexed citations
12.
Tao, Derrick L., et al.. (2018). More efficacious, equally safe: a meta-analysis comparing the safety of direct oral anticoagulants versus aspirin. Journal of Thrombosis and Thrombolysis. 46(1). 22–23. 2 indexed citations
13.
Tao, Derrick L., et al.. (2018). Evaluating the Effects of an Evidence-Based Hemostasis and Thrombosis Treatment Algorithm on Medical Practitioner and Trainee Clinical Decision-Making. Seminars in Thrombosis and Hemostasis. 44(4). 400–403. 2 indexed citations
14.
Tao, Derrick L., et al.. (2017). The Safety of Aspirin Vs. Direct Oral Anticoagulants: A Meta-Analysis of Currently Published Clinical Trials. Blood. 130. 3720–3720. 4 indexed citations
15.
Tao, Derrick L., Tomasz M. Beer, Alice Fung, et al.. (2017). Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision Making. JCO Precision Oncology. 1(1). 1–11. 7 indexed citations
16.
17.
Tao, Derrick L., et al.. (2016). Extended thromboprophylaxis with direct oral anticoagulants for medical patients: a systematic review and meta-analysis. Blood. 129(5). 653–655. 20 indexed citations
18.
Eilers, Grant, Jeffrey T. Czaplinski, Mark Mayeda, et al.. (2015). CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans. Molecular Cancer Therapeutics. 14(6). 1346–1353. 44 indexed citations
19.
Doyle, Leona A., Derrick L. Tao, & Adrián Mariño‐Enríquez. (2014). STAT6 is amplified in a subset of dedifferentiated liposarcoma. Modern Pathology. 27(9). 1231–1237. 132 indexed citations
20.
Lee, Cheng‐Han, Lien Hoang, Stephen Yip, et al.. (2013). Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement. Modern Pathology. 27(5). 751–757. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariella Sorarů Breakdown of academic impact, for papers by Angelika Bezan Breakdown of academic impact, for papers by Yoji Fukumoto Breakdown of academic impact, for papers by Doğan Uncu Breakdown of academic impact, for papers by Lee Chun Park Breakdown of academic impact, for papers by Yanjie Hao Breakdown of academic impact, for papers by Yuichi Tomiki Breakdown of academic impact, for papers by Hirohiko Kuroda Breakdown of academic impact, for papers by I. L. Ray-Coquard Breakdown of academic impact, for papers by Ferdinando Cananzi
Rankless by CCL
2026